Show results for
Refine by
Cancer Detection Suppliers Serving Denmark
66 companies found
based inMontpellier, FRANCE
SurgiMAb develops injectable fluorescent conjugates to be used during Fluorescence-Guided Surgery (FGS) by oncology surgeons so they can clearly delineate tumors and visualize infra-clinical size nodules invisible to their naked eyes. SurgiMab was ...
SurgiMab’s tumor-targeting fluorescent molecules enable real time visualization of tumor margins, tumor spread and micro-tumors which are invisible to the naked eye. As opposed to an indiscriminate contrast agent, this ability to specifically ...
based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
Targeted Radionuclide Therapy (TRT) or Peptide Receptor Radionuclide Therapy (PRRT) is a medical specialty using very small amounts of radioactive compounds, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer. Once ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
PancreaDix is an innovative, non-invasive signature in blood for: Confirming a Pancreatic cancer diagnosis. Detecting pre-malignant lesions that will evolve to cancer. Performing a differential ...
based inKaohsiung City, TAIWAN
EPED Inc. is a leading company in the field of minimally invasive surgery. Upholding the values of “safety, precision, and efficiency”, we strive constantly to develop innovative medical and dental navigation solutions. From education, training ...
EPROB Robotic Arm + AI is the newest member of the EPED Inc. family. Having been in production for nearly decade, a heavy emphasis on precision, safety, and minimally invasive surgeries are just some of the features that have been developed in that ...
based inCarlsbad, CALIFORNIA (USA)
We are a global medical technology company committed to providing peace of mind to patients and physicians alike through the use of MBI and PET as secondary screening and diagnostic tools. Both the LumaGEM ® Molecular Breast Imaging (MBI) system and ...
The LumaGEM® Molecular Breast Imaging system’s patented mounting mechanism allows the use of light breast immobilization for greater patient comfort during breast cancer imaging exam. The LumaGEM MBI system for breast cancer imaging ...
based inSan Diego, CALIFORNIA (USA)
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...
Liquid biopsies are a new powerful tool in cancer diagnostics that is transforming patient healthcare. Body fluids such as blood or urine are obtained from the patient and analyzed for the presence of circulating tumor DNA which is shed from the ...
based inParkville, AUSTRALIA
Rhythm Biosciences is interested in developing and commercialising Australian medical diagnostics technology for sale to national and international markets. For Rhythm Biosciences, ColoSTAT is the first proposed product-in-development, intended as ...
The ColoSTAT technology has the potential to become the new, first step screening test for people, who for personal, cultural or clinical reasons, elect to not participate in the existing screening programs for colorectal ...
based inHerndon, VIRGINIA (USA)
VIDAR Systems Corporation is a publicly held optical imaging technology manufacturing company, specializing in medical and non-destructive testing (NDT) imaging markets. VIDAR is owned by 3D Systems, a leading global provider of 3D content-to-print ...
CAD systems incorporate advanced pattern recognition and image analysis, requiring a film digitizer that meets the highest standards of image quality and reliability. These advanced systems enable radiologists to improve their ability to ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per ...
based inDunedin,, NEW ZEALAND
Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Our ...
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the ...
based inChicago, ILLINOIS (USA)
GE HealthCare operates as a leader in precision care, integrating advanced technologies with patient-focused solutions to enhance healthcare delivery. The company invests approximately $1 billion annually in research and development, focusing on ...
The Invenia ABUS 2.0 is designed as an FDA-approved ultrasound supplemental screening technology, aiming to improve cancer detection in women with dense breast tissue. It offers a 35.7% increase in ...
based inBerlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular ...
based inBensheim, GERMANY
We are a globally orientated German company with innovative products in the sector of point-of-care diagnostics and telemedical solutions that are used in clinics, practices and in everyone’s everyday life. Preventis GmbH was founded 2003 in ...
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 ...
based inMilan, ITALY
Tethis S.p.A is based in Milan, Italy, and is developing a novel workflow to bring liquid biopsy in the clinical practice for the precise management of cancer. Tethis’ technology points to standardization of the blood sample preparation to provide ...
based inKowloon Bay, HONG KONG
Hybribio, a leader in molecular diagnostic products in China, is engaged in the nucleic acid diagnostic field. It provides a full operation chain from research and development to production and sales. The company's capabilities are enriched by an ...
The Stool DNA Methylation Real-time PCR Kit serves as a diagnostic tool for individuals at high risk of colorectal cancer, facilitating in vitro qualitative detection of methylated SDC2 and TFPI2 genes within ...
based inValkenswaard, NETHERLANDS
Established in 2004, 2M Engineering is an esteemed privately-owned SME enterprise renowned for its cutting-edge proficiency in sensors. Our expertise is specifically applied in the domains of wearables, medical devices, and industrial and ...
Driving Innovation Through our comprehensive product creation services; At 2M, we are experts in creating cutting-edge smart sensing solutions that propel innovation in various industries. Our services encompass a wide range of offerings, from ...
based inNijmegen, NETHERLANDS
ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection. They have led research projects in the field for over ...
The resulting product, Transpara, has featured in multiple peer-reviewed publications that show it enables significant clinical improvements to the timely diagnosis of breast cancer. “Transpara is now being used by radiologists in clinical ...
based inSan Diego, CALIFORNIA (USA)
CureMetrix is committed to the advancement of technology that will improve cancer survival rates worldwide. Our research is focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis ...
cmDensity An investigational, artificial intelligence- based triage software that helps radiologists classify density accurately and ...
based inGeorgetown, TEXAS (USA)
Ezra is focused on early cancer detection through the use of full-body MRI scans. Given that early detection significantly increases survival rates, Ezra's annual Full Body Scans aim to identify cancer signs early, potentially preventing late-stage ...
Ezra offers advanced MRI-based full-body scans aimed at early cancer detection. The service employs 3 Tesla (3T) MRI technology, known for its higher-resolution imaging and superior signal-to-noise ratio, alongside ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
Trublood is an advanced non-invasive blood test (which provides diagnostically relevant information about cancers via a safe, simple and quick blood draw). Trublood® evaluates blood sample to detect ...